BeOne Medicines
ONC
#652
Rank
$35.73 B
Marketcap
$322.90
Share price
-2.56%
Change (1 day)
55.52%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

BeOne Medicines (ONC) - Net assets

Net assets on the balance sheet as of September 2025 : $4.12 Billion USD

According to BeOne Medicines's latest financial reports the company has $4.12 Billion USD in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

BeOne Medicines - Net assets on balance sheet (from 2014 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$$3.33 B-5.8%
2023-12-31$$3.53 B-19.3%
2022-12-31$$4.38 B-28.52%
2021-12-31$$6.13 B58.5%
2020-12-31$$3.86 B295.48%
2019-12-31$$0.97 B-44.21%
2018-12-31$$1.75 B156.29%
2017-12-31$$0.68 B93.88%
2016-12-31$$0.35 B374.85%
2015-12-31$$74.31 M188.42%
2014-12-31$$25.76 M-166.54%
2013-12-31$-$38.73 Million

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Onconova Therapeutics
ONTX
$6.01 M-99.85%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
$1.30 B-68.38%๐Ÿ‡บ๐Ÿ‡ธ USA